APA (7th ed.) Citation

F, A., M, B., HR, K., & M, M. (2024). Turning the tide: Pembrolizumab's triumph in adjuvant RCC therapy. Medical oncology (Northwood, London, England), 41(10), 242. https://doi.org/10.1007/s12032-024-02486-3

Chicago Style (17th ed.) Citation

F, Attieh, Boutros M, Kourie HR, and Mahrous M. "Turning the Tide: Pembrolizumab's Triumph in Adjuvant RCC Therapy." Medical Oncology (Northwood, London, England) 41, no. 10 (2024): 242. https://doi.org/10.1007/s12032-024-02486-3.

MLA (9th ed.) Citation

F, Attieh, et al. "Turning the Tide: Pembrolizumab's Triumph in Adjuvant RCC Therapy." Medical Oncology (Northwood, London, England), vol. 41, no. 10, 2024, p. 242, https://doi.org/10.1007/s12032-024-02486-3.